CordenPharma is a leading CDMO for cGMP development & manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligos, & osd.
Engineering, Procurement, and Construction of Pill Manufacturing/ Pharmaceutical Machinery US$150,000.00-300,000.00 / Piece GMP Approved Solid Dose Facility Solution / Pharmaceutical & Medical From a to Z US$200,000.00-800,000.00 / Pi...
In other words, the client can simply "turn the key" and start using the facility without having to worry about the intricate details of setting up the manufacturing process and equipment. Our Advantages 1.Comprehensive Solution: Offers a complete package that...
It adopts optimization design for meeting the characteristics of Chinese medicine and the requirement of GMP, it has the characteristics of compact mechanism, small volume, lower noise, precision filling dosage, multi-function, stably running etc. ...
Pqfb Full-Turnover Cover Top Discharge Pharma Centrifuges - GMP, Find Details and Price about Centrifuge Top Discharge Centrifuge from Pqfb Full-Turnover Cover Top Discharge Pharma Centrifuges - GMP - Jiangsu Huada Centrifuge Co., Ltd.
Full Automatic Hard Capsule Filling Polyethylene Filler Board Machine Filler Pharmaceutical Size 00 0 1 2 3 4 5 Safety Capsule Machine, Find Details and Price about Pill Capsule Machine Pharma Capsule Filling Machine from...
Interim data from TATCIST study of FPI-2265 to be presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting in April Fusion is now producing and shipping clinical doses of FPI-2265 from its state-of-the-art GMP manufacturing facility HAMILTON, ON and B...
GEMBLOUX, Belgien,8. Dezember 2023/PRNewswire/ -- Full-Life Technologies (Full-Life), ein voll integriertes globales Radiotherapeutika-Unternehmen, gab heute den Bau seiner neuen Good Manufacturing Practices (G...
The overall pooled utilization of GMP service among children under two years of age in Ethiopia was 23.21% (95% CI: 16.02, 30.41, I2 = 97.27% & P = 0.0001). Mothers who received counselling on GMP service (OR = 3.16 (95%CI: 2.49-4.00), parents who use family health...
Human iPSCs' derivation and use in clinical studies are transforming medicine. Yet, there is a high cost and long waiting time associated with autologous iPS-based cellular therapy, and the genetic engineering of hypo-immunogenic iPS cell lines is hampered with numerous hurdles. Therefore, it is...